A Novel Transthyretin Variant (p.Phe-84-Tyr) for Hereditary Transthyretin Amyloidosis with Polyneuropathy and Early Ocular Findings

Authors

  • Karla Cárdenas-Soto Department of Neurology, Instituto Nacional De Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico Author
  • Alechka Arumir-Lira Department of Neurology, Instituto Nacional De Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico Author
  • Alejandra Gonzalez-Duarte Department of Neurology, Instituto Nacional De Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico Author
  • Rivera-De La Parra David Centro de atención integral del paciente con diabetes. Instituto Nacional De Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico Author
  • Pablo Hernandez Reyes Department of Cardiology, Instituto Nacional De Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico Author

DOI:

https://doi.org/10.33425/2693-1516.1042

Keywords:

Hereditary amyloidosis, Transthyretin familial amyloid polyneuropath

Abstract

Hereditary transthyretin amyloidosis (hATTR) is a rare disease that affects multiple systems and is triggered by a mutation in the transthyretin (TTR) gene. This report introduces a new pathogenic variant, Phe84Tyr, identified in a patient with no known family history of amyloidosis. The patient exhibited polyneuropathy, cardiomyopathy, and significant ocular involvement, potentially a unique characteristic of this variant.

Published

2025-07-30

Issue

Section

Articles